C
CAXTON CORP
CAXTON CORP is an institution, managing $22.9M across 12 long positions as of Q3 2025 with 87% Healthcare concentration, 100% concentrated in top 10 holdings, and 82% allocation to RZLT.
- Portfolio Value
- $22.9M
- Positions
- 12
- Top Holding
- RZLT at 81.7%
- Last Reported
- Q3 2025
Top Holdings
Largest long holdings in CAXTON CORP's portfolio (99.8% of total portfolio)
GthenH
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $18.7M | 81.70% | +$3.6M Bought | 2.19% 2.0M shares | |
Unknown Unknown | $2.6M | 11.33% | +$829.7K Bought | — 7.3K shares | |
Insurance - Diversified Financial Services | $327.5K | 1.43% | +$9.6K Bought | 0.00% 651.0 shares | |
Biotechnology Healthcare | $318.5K | 1.39% | -$83.3K Sold | 0.04% 27.0K shares | |
Biotechnology Healthcare | $268.1K | 1.17% | — | 0.02% 13.1K shares | |
Biotechnology Healthcare | $187.3K | 0.82% | +$35.1K Bought | 0.03% 53.5K shares | |
Unknown Unknown | $172.8K | 0.76% | — | 0.02% 10.9K shares | |
Biotechnology Healthcare | $137.9K | 0.60% | — | 0.05% 23.0K shares | |
Biotechnology Healthcare | $115.1K | 0.50% | — | 0.03% 17.3K shares | |
Biotechnology Healthcare | $26.6K | 0.12% | — | 0.02% 16.4K shares |
Changes
Portfolio activity, position movements, and quarter-over-quarter changes in CAXTON CORP's latest filing
GthenC
Market Value
Q/Q Change
Net Flows % of MV
Turnover Ratio
New Purchases
Added To
Sold Out Of
Reduced Holdings
Increased Positions
| Position | Shares Δ |
|---|---|
New | |
+47.13% | |
+23.87% | |
+23.09% | |
+3.01% |
Decreased Positions
| Position | Shares Δ |
|---|---|
-20.73% |
Analytics
Portfolio insights and performance metrics for CAXTON CORP
GthenA